GMED Globus Medical Inc: Debt to Equity

Globus Medical, Inc. (GMED) develops innovative tools and implants for spinal surgery, maintaining high margins through an extensive network of manufacturing plants. The company's revenue is based on wholesale deliveries of robotics and high-tech products to major hospitals. Patent protection and strict FDA regulations create a robust barrier to entry for competitors. The market valuation visualization on GURU.Markets shows that this figure is 0.02.

This metric is calculated as the ratio of total liabilities to equity, determining the proportion of borrowed funds within the company's asset financing structure. Low leverage confirms the resilience of Globus Medical, Inc. (GMED) to rising interest rates, which is critical during the capital-intensive implementation of robotic lines and AI-driven production control, while the debt-to-equity ratio history allows for an assessment of liquidity gap risks.